Related Experiment Video
Updated: Jul 10, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Postcardiotomy cardiogenic shock: the role of ventricular assist devices
Kevin Hagan1, Elena Casanova-Ghosh
1Lankenau Hospital, Lankenau MSB, Suite 280, 100 Lancaster Avenue, Wynnewood, PA 19096, USA. hagank@mlhs.org
Abstract:
Postcardiotomy cardiogenic shock (PCCS) remains a life-threatening complication of cardiac surgery. Although survival rates have doubled in the past decade, PCCS continues to result in significant morbidity and mortality. Factors contributing to improved outcomes include early recognition of shock, early application of ventricular assist device (VAD) technology in cases of refractory shock, better technology, better surgical application (less technical error), application of treatment protocols, and assignment of management to specially trained personnel. A systematic approach to the management of PCCS can facilitate consistent care. This same approach can be applied to all forms of shock. VAD technology provides an opportunity for survival when other medical and surgical options fail.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiopulmonary Resuscitation IV: Pharmacological Management
Heart Failure VI: Adjunct Therapies
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiopulmonary Resuscitation III: AED Use
